Pregnancy and Healthy Childbirth in a 37 Year-Old Patient with Diverticular Disease
https://doi.org/10.22416/1382-4376-2020-30-5-58-62
Abstract
Aim. To describe a clinical case of pregnancy and healthy labour in a young female patient with uncomplicated diverticular disease (DD).
Key points. In recent years, DD is more frequently observed in younger patients. A 37-yo woman manifested the symptoms of periodic intense abdominal pain and constant abdominal discomfort. Colonic DD was diagnosed with irrigoscopy. A high-fibre diet, rifaximin-α at 400 mg twice a day for one week, once a month for six months, and topical anti-inflammatory therapy were prescribed. Clinical symptoms were eradicated upon the treatment. Unaware of pregnancy, the patient had another course of rifaximin-α at the second week of gestation, after which the therapy was stopped. Rifaximin-α, which has a poor intestinal absorption, did not affect the foetal development. A caesarean childbirth was healthy, the newborn was delivered on term with no complications (Apgar score 8).
Conclusion. DD should be included in differential diagnosis for patients with non-specific symptoms (abdominal pain, bloating and discomfort), regardless of young age. No protocols are currently accepted for the DD management during gestation. In the clinical case reported, a patient having diverticular disease and a rifaximin-α therapy at an early term of gestation proceeded without complications for herself and the foetus.
About the Authors
P. S. AndreevRussian Federation
Pavel S. Andreev - Cand. Sci. (Med.), Physician (coloproctology), Assoc. Prof., Chair of Hospital Surgery
443099, г. Самара, ул. Чапаевская, д. 89
S. E. Katorkin
Russian Federation
Sergey E. Katorkin - Dr. Sci. (Med.), Physician (coloproctology), Head of the Chair and Clinic of Hospital Surgery
443099, г. Самара, ул. Чапаевская, д. 89
O. E. Davydova
Russian Federation
Olga E. Davydova - Cand. Sci. (Med.), Physician (coloproctology), Clinic of Hospital Surgery
443099, г. Самара, ул. Чапаевская, д. 89
References
1. Ivashkin V.T., Shelygin Yu.A., Achkasov S.I., Vasilyev S.V., Grigoryev Ye.G., Dudka V.V., et al. Diagnostics and treatment of diverticular disease of the colon: guidelines of the Russian gastroenterological Association and Russian Association of Coloproctology. Russ J Gastroenterol Hepatol Coloproctol. 2016;26(1):65–80 (In Russ.).
2. Tursi A. A critical appraisal of advances in the diagnosis of diverticular disease. Expert Rev Gastroenterol Hepatol. 2018;12(8):791–96 DOI: 10.1080/17474124.2018.1487288
3. Tursi A. Diverticulosis today: unfashionable and still under-researched. Therap Adv Gastroenterol. 2016;9(2):213–28. DOI: 10.1177/1756283X15621228
4. Zaidi E., Daly B. CT and clinical features of acute diverticulitis in an urban US population: rising frequency in young, obese adults. Am J Roentgenology. 2006;187(3):689–94. DOI: 10.2214/AJR.05.0033. PMID: 16928931
5. Schweitzer J., Casillas R.A., Collins J.C. Acute diverticulitis in the young adult is not “virulent”. Am Surg. 2002;68(12):1044–7.
6. Guzzo J., Hyman N. Diverticulitis in young patients: is resection after a single attack always warranted? Dis Colon Rectum. 2004;47(7):1187–90; discussion 1190–1. DOI: 10.1007/s10350-004-0546-7
7. Nguyen G.C., Sam J., Anand N. Epidemiological trends and geographic variation in hospital admissions for diverticulitis in the United States. World J Gastroenterol. 2011;17(12):1600–5. DOI: 10.3748/wjg.v17.i12.1600
8. Etzioni D.A., Mack T.M., Beart R.W., Kaiser A.M. Diverticulitis in the United States: 1998–2005: changing patterns of disease and treatment. Ann Surg. 2009;249(2):210–7. DOI: 10.1097/SLA.0b013e3181952888
9. Cuomo R., Barbara G., Andreozzi P., Bassotti G., Casetti T., Grassini M., et al. Symptom patterns can distinguish diverticular disease from irritable bowel syndrome. Eur J Clin Invest. 2013;43(11):1147–55. DOI: 10.1111/eci.12152
10. Shifrin O.S., Poluektova E.A., Korolev A.V., Semenova T.I., Shein M.V., Leksikova G.N., et al. Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice. Russ J Gastroenterol Hepatol Coloproctol. 2020;30(1):14–25 (In Russ.)]. DOI: 10.22416/1382-4376-2020-30-1-14-25
11. Bianchi M., Festa V., Moretti A., Ciaco A., Mangone M., Tornatore V., et al. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther. 2011;33(8):902–10.DOI: 10.1111/j.1365-2036.2011.04606.x
12. Stallinger S., Eller N., Högenauer C. Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease. Wien Klin Wochenschr. 2014;126(1–2):9–14. DOI: 10.1007/s00508-013-0447-7
13. Strate L.L., Morris A.M. Epidemiology, Pathophysiology, and Treatment of Diverticulitis. Gastroenterology. 2019;156(5):1282–98. DOI: 10.1053/j.gastro.2018.12.033
14. Jiang Z.D., Ke S., Palazzini E., Riopel L., Dupont H. In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrob Agents Chemother. 2000;44(8):2205–06. DOI: 10.1128/aac.44.8.2205-2206.2000
15. Maccaferri S., Vitali B., Klinder A., Kolida S., Ndagijimana M., Laghi L., et al. Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: an in vitro approach using a continuous culture colonic model system. J Antimicrob Chemother. 2010;65(12):2556–65. DOI: 10.1093/jac/dkq345
16. Longo S.A., Moore R.C., Canzoneri B.J., Robichaux A. Gastrointestinal Conditions during Pregnancy. Clinics in Colon and Rectal Surgery. 2010;23(2):80–9. DOI: 10.1055/s-0030-1254294
Review
For citations:
Andreev P.S., Katorkin S.E., Davydova O.E. Pregnancy and Healthy Childbirth in a 37 Year-Old Patient with Diverticular Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020;30(5):58-62. (In Russ.) https://doi.org/10.22416/1382-4376-2020-30-5-58-62